Chapter 4 —— 91 —— 24. Maggio, I.; Holkers, M.; Liu, J.; Janssen, J.M.; Chen, X.; Gonçalves, M.A.. Adenoviral vector delivery of RNA-guided CRISPR/Cas9 nuclease complexes induces targeted mutagenesis in a diverse array of human cells. Sci. Rep. 2014, 4, 5105. 25. Wang, Q.; Liu, J.; Janssen, J.M.; Tasca, F.; Mei, H.; Gonçalves, M.A.F.V.. Broadening the reach and investigating the potential of prime editors through fully viral gene-deleted adenoviral vector delivery. Nucleic Acids Res. 2021, 49, 11986–12001. 26. Tasca, F.; Brescia, M.; Wang, Q.; Liu, J.; Janssen, J.M.; Szuhai, K.; Gonçalves, M.A.F.V.. Large-scale genome editing based on high-capacity adenovectors and CRISPR-Cas9 nucleases rescues full-length dystrophin synthesis in DMD muscle cells. Nucleic Acids Res. 2022, 50, 7761–7782. 27. Janssen, J.M.; Liu, J.; Skokan, J.; Gonçalves, M.A.; de Vries,A.A.. Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells. J. Gene Med. 2013, 15, 1–11. 28. Evans, R.K.; Nawrocki, D.K.; Isopi, L.A.; Williams, D.M.; Casimiro, D.R.; Chin, S.; Chen, M.; Zhu, D.M.; Shiver, J.W.; Volkin, D.B.. Development of stable liquid formulations for adenovirus-based vaccines. J. Pharm. Sci. 2004, 93, 2458–2475. 29. Slaymaker, I.M.; Gao, L.; Zetsche, B.; Scott, D.A.; Yan, W.X.; Zhang, F.. Rationally engineered Cas9 nucleases with improved specificity. Science 2016, 351, 84–88. 30. Maggio, I.; Zittersteijn, H.A.; Wang, Q.; Liu, J.; Janssen, J.M.; Ojeda, I.T.; van der Maarel, S.M.; Lankester, A.C.; Hoeben, R.C.; Gonçalves, M.A.F.V.. Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components. Gene Ther. 2020, 27, 209–225. 31. Janssen, J.M.; Chen, X.; Liu, J.; Gonçalves, M.A.F.V.. The chromatin structure of CRISPR-Cas9 target DNA controls the balance between mutagenic and homologydirected gene-editing events. Mol. Ther. Nucleic Acids 2019, 16, 141–154. 32. Dang, Y.; Jia, G.; Choi, J.; Ma, H.; Anaya, E.; Ye, C.; Shankar, P.; Wu, H.. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency. Genome Biol. 2015, 16, 280. 33. Pelascini, L.P.; Janssen, J.M.; Gonçalves, M.A.. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and nondividing cells. Hum. Gene Ther. 2013, 24, 78–96. 34. Chen, X.; Tasca, F.; Wang, Q.; Liu, J.; Janssen, J.M.; Brescia, M.D.; Bellin, M.; Szuhai, K.; Kenrick, J.; Frock, R.L.; et al. Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking. Nucleic Acids Res. 2020, 48, 974–995. 35. Wang, Q.; Liu, J.; Janssen, J.M.; Le Bouteiller, M.; Frock, R.L.; Gonçalves, M.A.F.V..
RkJQdWJsaXNoZXIy MTk4NDMw